Search research articles
Contact Us
Filters
Showing results (131-140 of 160) with videos related to
Page
of 16
Sort By:
Elife
|
April 29, 2025
An atypical basement membrane forms a midline barrier during left-right asymmetric gut development in the chicken embryo
Cora Demler, John C Lawlor, Ronit Yelin, et al.
European Journal of Haematology
|
May 31, 2023
Venetoclax-based salvage therapy for adult patients with relapsed/refractory acute lymphoblastic leukemia
Jonathan Canaani, Avraham Frisch, Daniel A Pollyea, et al.
Anticancer Research
|
November 7, 2018
Hairy Cell Leukemia: Retrospective Analysis of Demographic Data and Outcome of 203 Patients from 12 Medical Centers in Israel
Michal Inbar, Yair Herishanu, Neta Goldschmidt, et al.
Aging Cell
|
October 29, 2022
SIAH proteins regulate the degradation and intra-mitochondrial aggregation of PINK1: Implications for mitochondrial pathology in Parkinson's disease
Fatimah Abd Elghani, Hazem Safory, Haya Hamza, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
September 21, 2010
Improved DNA vaccination by skin-targeted delivery using dry-coated densely-packed microprojection arrays
Xianfeng Chen, Angela Shaulov Kask, Michael L Crichton, et al.
European Journal of Immunology
|
May 22, 2008
Selective activation, expansion, and monitoring of human iNKT cells with a monoclonal antibody specific for the TCR alpha-chain CDR3 loop
Mark A Exley, Runhua Hou, Angela Shaulov, et al.
Annals of Hematology
|
March 21, 2020
Ixazomib-based regimens for relapsed/refractory multiple myeloma: are real-world data compatible with clinical trial outcomes? A multi-site Israeli registry study
Yael C Cohen, Hila Magen, Noa Lavi, et al.
Haematologica
|
October 6, 2022
Development and manufacture of novel locally produced anti-BCMA CAR T cells for the treatment of relapsed/refractory multiple myeloma: results from a phase I clinical trial
Nathalie Asherie, Shlomit Kfir-Erenfeld, Batia Avni, et al.
European Journal of Haematology
|
April 25, 2023
Risk factors and outcomes of COVID-19 in adult patients with hematological malignancies: A single-center study showing lower than expected rates of hospitalization and mortality
Shlomzion Aumann, Uria Tsubary, Boaz Nachmias, et al.
Leukemia Research
|
June 2, 2019
Primary peg-filgrastim prophylaxis versus filgrastim given "on demand" for neutropenia during therapy with cladribine for hairy cell leukemia
Tamar Tadmor, Ilana Levy, Yair Herishanu, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 160) with videos related to
Sort By:
Page
of 16
Elife
|
April 29, 2025
An atypical basement membrane forms a midline barrier during left-right asymmetric gut development in the chicken embryo
Cora Demler, John C Lawlor, Ronit Yelin, et al.
European Journal of Haematology
|
May 31, 2023
Venetoclax-based salvage therapy for adult patients with relapsed/refractory acute lymphoblastic leukemia
Jonathan Canaani, Avraham Frisch, Daniel A Pollyea, et al.
Anticancer Research
|
November 7, 2018
Hairy Cell Leukemia: Retrospective Analysis of Demographic Data and Outcome of 203 Patients from 12 Medical Centers in Israel
Michal Inbar, Yair Herishanu, Neta Goldschmidt, et al.
Aging Cell
|
October 29, 2022
SIAH proteins regulate the degradation and intra-mitochondrial aggregation of PINK1: Implications for mitochondrial pathology in Parkinson's disease
Fatimah Abd Elghani, Hazem Safory, Haya Hamza, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
September 21, 2010
Improved DNA vaccination by skin-targeted delivery using dry-coated densely-packed microprojection arrays
Xianfeng Chen, Angela Shaulov Kask, Michael L Crichton, et al.
European Journal of Immunology
|
May 22, 2008
Selective activation, expansion, and monitoring of human iNKT cells with a monoclonal antibody specific for the TCR alpha-chain CDR3 loop
Mark A Exley, Runhua Hou, Angela Shaulov, et al.
Annals of Hematology
|
March 21, 2020
Ixazomib-based regimens for relapsed/refractory multiple myeloma: are real-world data compatible with clinical trial outcomes? A multi-site Israeli registry study
Yael C Cohen, Hila Magen, Noa Lavi, et al.
Haematologica
|
October 6, 2022
Development and manufacture of novel locally produced anti-BCMA CAR T cells for the treatment of relapsed/refractory multiple myeloma: results from a phase I clinical trial
Nathalie Asherie, Shlomit Kfir-Erenfeld, Batia Avni, et al.
European Journal of Haematology
|
April 25, 2023
Risk factors and outcomes of COVID-19 in adult patients with hematological malignancies: A single-center study showing lower than expected rates of hospitalization and mortality
Shlomzion Aumann, Uria Tsubary, Boaz Nachmias, et al.
Leukemia Research
|
June 2, 2019
Primary peg-filgrastim prophylaxis versus filgrastim given "on demand" for neutropenia during therapy with cladribine for hairy cell leukemia
Tamar Tadmor, Ilana Levy, Yair Herishanu, et al.
Page
of 16